4D Bioprinting Market

4D Bioprinting Market by Type of Technology, Application Area, End-user and Key Geographical Regions: Industry Trends and Global Forecasts, 2023-2035

  • Lowest Price Guaranteed From USD 4,799

  • Companies Covered
    71

  • Pages
    183

  • View Count
    9932

Table Of Contents

1. PREFACE
1.1. Scope of the Report
1.2. Market Segmentation
1.3. Research Methodology
1.4. Key Questions Answered
1.5. Chapter Outlines

2. EXECUTIVE SUMMARY

3. INTRODUCTION
3.1. Chapter Overview
3.2. Overview of 4D Bioprinting
3.3. Working Principle of 4D Bioprinting
3.3.1. Stimuli Responsive Materials in 4D Bioprinting
3.3.1.1. Physical Factors
3.3.1.2. Chemical Factors
3.3.2. Technologies Used in 4D Bioprinting

3.4. Applications of 4D Bioprinting
3.5. Limitations Associated with 4D Bioprinting
3.6. Future Perspectives

4. 4D BIOPRINTERS: MARKET LANDSCAPE
4.1. Chapter Overview
4.2. 4D Bioprinters: Overall Market Landscape
4.2.1. Analysis by Status of Development
4.2.2. Analysis by Type of Biomaterial
4.2.3. Analysis by Status of Development and Type of Biomaterial
4.2.4. Analysis by Type of Technology
4.2.5. Analysis by Status of Development and Type of Technology
4.2.6. Analysis by Type of Stimulus Used
4.2.7. Analysis by Status of Development and Type of Stimulus Used
4.2.8. Analysis by Product Specifications
4.2.9. Analysis by Application Area(s)
4.2.10. Analysis by End-User(s)

4.3. 4D Bioprinter Developers
4.3.1. Analysis by Year of Establishment
4.3.2. Analysis by Organization Size
4.3.3. Analysis by Location of Headquarters (Region-wise)
4.3.4. Analysis by Organization Size and Location of Headquarters (Region-wise)
4.3.5. Analysis by Location of Headquarters (Country-wise)

5. SMART BIOMATERIALS: MARKET LANDSCAPE
5.1. Chapter Overview
5.2. Smart Biomaterials: Overall Market Landscape
5.2.1. Analysis by Status of Development
5.2.2. Analysis by Type of Biomaterial
5.2.3. Analysis by Status of Development and Type of Biomaterial
5.2.4. Analysis by Form of Biomaterial
5.2.5. Analysis by Type of Stimulus Used
5.2.6. Analysis by Status of Development and Type of Stimulus Used
5.2.7. Analysis by Application Area(s)

5.3. Smart Biomaterials Developers
5.3.1. Analysis by Year of Establishment
5.3.2. Analysis by Organization Size
5.3.3. Analysis by Location of Headquarters (Region-wise)
5.3.4. Analysis by Organization Size and Location of Headquarters (Region-wise)
5.3.5. Analysis by Location of Headquarters (Country-wise)

6. BENCHMARKING ANALYSIS
6.1. Chapter Overview
6.2. Benchmarking Analysis: 4D Bioprinter Developers
6.2.1. Assumptions and Key Parameters
6.2.2. Methodology
6.2.3. Benchmarking Analysis: Peer Groups
6.2.3.1. Benchmarking Analysis: North America (Peer Group I)
6.2.3.2. Benchmarking Analysis: North America (Peer Group II)
6.2.3.3. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group III)

6.2.3.4. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group IV)

6.2.3.5. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group V)

6.3. Benchmarking Analysis: Smart Biomaterials Developers
6.3.1. Assumptions and Key Parameters
6.3.2. Methodology
6.3.3. Benchmarking Analysis: Peer Groups
6.3.3.1. Benchmarking Analysis: North America (Peer Group I)
6.3.3.2. Benchmarking Analysis: North America (Peer Group II)
6.3.3.3. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group III)

6.3.3.4. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group IV)

6.3.3.5. Benchmarking Analysis: Europe, Asia-Pacific and Rest of the World (Peer Group V)

7. PRODUCT COMPETITIVENESS ANALYSIS
7.1. Chapter Overview
7.2. Assumptions and Key Parameters
7.3. Methodology
7.4. Product Competitiveness Analysis: Analysis by Location of Headquarters of 4D Bioprinter Developers

7.4.1. Product Competitiveness Analysis: 4D Bioprinters Developed by North  America based Players

7.4.2. Product Competitiveness Analysis: 4D Bioprinters Developed by Europe based Players

7.4.3. Product Competitiveness Analysis: 4D Bioprinters Developed by Asia-Pacific and Rest of the World-based Players

8. COMPANY PROFILES
8.1. Chapter Overview
8.2. List of 4D Bioprinter Developers
8.2.1. Poietis
8.2.1.1. Company Overview
8.2.1.2. Product Portfolio
8.2.1.3. Recent Developments and Future Outlook

8.2.2. REGENHU
8.2.2.1. Company Overview
8.2.2.2. Product Portfolio
8.2.2.3. Recent Developments and Future Outlook

8.2.3. ROKIT Healthcare
8.2.3.1. Company Overview
8.2.3.2. Product Portfolio
8.2.3.3. Recent Developments and Future Outlook

8.2.4. SMART3D
8.2.4.1. Company Overview
8.2.4.2. Product Portfolio
8.2.4.3. Recent Developments and Future Outlook

8.2.5. Stratasys
8.2.5.1.1. Company Overview
8.2.5.1.2. Financial Information
8.2.5.1.3. Product Portfolio
8.2.5.1.4. Recent Developments and Future Outlook

8.2.6. VIVAX BIO
8.2.6.1. Company Overview
8.2.6.2. Product Portfolio
8.2.6.3. Recent Developments and Future Outlook

8.3. List of Smart Biomaterials Developers
8.3.1. DirectSync Surgical
8.3.1.1. Company Overview
8.3.1.2. Product Portfolio
8.3.1.3. Recent Developments and Future Outlook

8.3.2. Enovis
8.3.2.1. Company Overview
8.3.2.2. Financial Information
8.3.2.3. Product Portfolio
8.3.2.4. Recent Developments and Future Outlook

8.3.3. Ferentis
8.3.3.1. Company Overview
8.3.3.2. Product Portfolio
8.3.3.3. Recent Developments and Future Outlook

8.3.4. Sculpteo
8.3.4.1. Company Overview
8.3.4.2. Product Portfolio
8.3.4.3. Recent Developments and Future Outlook

9. PUBLICATION BENCHMARKING ANALYSIS
9.1. Chapter Overview
9.2. Scope and Methodology
9.2.1. Analysis by Year of Publication
9.2.2. Analysis by Type of Article
9.2.3. Word Cloud Analysis: Emerging Focus Areas
9.2.4. Popular Publishers: Analysis by Number of Publications 
9.2.5. Popular Journals: Analysis by Number of Publications
9.2.6. Analysis by Journal Impact Factor
9.2.7. Popular Journals: Analysis by Journal Impact Factor
9.2.8. Popular Funding Bodies: Analysis by Number of Publications

9.2.9. Publications: Timeline Analysis
9.2.9.1. Timeline Analysis of Article Type
9.2.9.2. Timeline Analysis of Journal Impact Factor Range

9.2.10. Publication Benchmarking

10. PORTER’S FIVE FORCES ANALYSIS
10.1. Chapter Overview
10.2. Assumptions and Key Parameters
10.3. Methodology
10.3.1. Threats of New Entrants
10.3.2. Bargaining Power of Buyers
10.3.3. Bargaining Power of Suppliers
10.3.4. Threats of Substitute Products
10.3.5. Rivalry Among Existing Companies

10.4. Concluding Remarks

11. MARKET FORECAST AND OPPORTUNITY ANALYSIS
11.1. Chapter Overview
11.2. Forecast Methodology and Key Assumptions

11.3. Overall 4D Bioprinting Market, 2023-2035
11.3.1. 4D Bioprinting Market, 2028 and 2035: Distribution by Type of Technology
11.3.1.1. 4D Bioprinting Market for Extrusion-based Technology, 2023-2035
11.3.1.2. 4D Bioprinting Market for Laser-based Technology, 2023-2035
11.3.1.3. 4D Bioprinting Market for Inkjet-based Technology, 2023-2035
11.3.1.4. 4D Bioprinting Market for Other Technologies, 2023-2035

11.3.2. 4D Bioprinting Market, 2028 and 2035: Distribution by Application Area
11.3.2.1. 4D Bioprinting Market for Biomedical Applications, 2023-2035
11.3.2.2. 4D Bioprinting Market for Other Applications, 2023-2035

11.3.3. 4D Bioprinting Market, 2028 and 2035: Distribution by End-User
11.3.3.1. 4D Bioprinting Market for Pharmaceutical and Biotechnology Companies, 2023-2035

11.3.3.2. 4D Bioprinting Market for Academic Research and Development, 2023-2035

11.3.3.3. 4D Bioprinting Market for Other End-Users, 2023-2035

11.3.4. 4D Bioprinting Market, 2028 and 2035: Distribution by Key Geographical Regions

11.3.4.1. 4D Bioprinting Market in North America, 2023-2035
11.3.4.2. 4D Bioprinting Market in Europe, 2023-2035
11.3.4.3. 4D Bioprinting Market in Asia-Pacific, 2023-2035
11.3.4.4. 4D Bioprinting Market in Latin America, 2023-2035
11.3.4.5. 4D Bioprinting Market in Middle East and North Africa, 2023-2035

12. CONCLUDING REMARKS 

13. EXECUTIVE INSIGHTS
13.1. Chapter Overview
13.2. Avay Biosciences
13.2.1. Company Overview 
13.2.2. Interview Transcript: Chief Operating Officer

13.3. CURAM
13.3.1. Company Overview 
13.3.2. Interview Transcript: Doctoral Candidate

13.3. Independent Consultant
13.3.1. Interview Transcript

14. APPENDIX I: TABULATED DATA

15. APPENDIX II: LIST OF COMPANIES AND ORGANIZATIONS

List Of Figures

Figure 2.1 Executive Summary: Current Market Landscape of 4D Bioprinters
Figure 2.2 Executive Summary: Current Market Landscape of Smart Biomaterials
Figure 2.3 Executive Summary: Publication Benchmarking Analysis
Figure 2.4 Executive Summary: Market Forecast and Opportunity Analysis
Figure 3.1 Steps Involved in Bioprinting
Figure 3.2 Steps Involved in 4D Bioprinting
Figure 3.3 Laws of 4D Printing Structures
Figure 3.4 Limitations Associated with 4D Bioprinting
Figure 4.1 4D Bioprinters: Distribution by Status of Development
Figure 4.2 4D Bioprinters: Distribution by Type of Biomaterial
Figure 4.3 4D Bioprinters: Distribution by Status of Development and Type of Biomaterial
Figure 4.4 4D Bioprinters: Distribution by Type of Technology
Figure 4.5 4D Bioprinters: Distribution by Status of Development and Type of Technology
Figure 4.6 4D Bioprinters: Distribution by Type of Stimulus Used
Figure 4.7 4D Bioprinters: Distribution by Status of Development and Type of Stimulus Used
Figure 4.8 4D Bioprinters: Distribution by Product Specifications
Figure 4.9 4D Bioprinters: Distribution by Application Area(s)
Figure 4.10 4D Bioprinters: Distribution by End-User(s)
Figure 4.11 4D Bioprinter Developers: Distribution by Year of Establishment
Figure 4.12 4D Bioprinter Developers: Distribution by Organization Size
Figure 4.13 4D Bioprinter Developers: Distribution by Location of Headquarters (Region-wise)
Figure 4.14 4D Bioprinter Developers: Distribution by Organization Size and Location of Headquarters (Region-wise)
Figure 4.15 4D Bioprinter Developers: Distribution by Location of Headquarters (Country-wise)
Figure 5.1 Smart Biomaterials: Distribution by Status of Development
Figure 5.2 Smart Biomaterials: Distribution by Type of Biomaterial
Figure 5.3 Smart Biomaterials: Distribution by Status of Development and Type of Biomaterial
Figure 5.4 Smart Biomaterials: Distribution by Form of Biomaterial
Figure 5.5 Smart Biomaterials: Distribution by Type of Stimulus Used
Figure 5.6 Smart Biomaterials: Distribution by Status of Development and Type of Stimulus Used
Figure 5.7 Smart Biomaterials: Distribution by Application Area(s)
Figure 5.8 Smart Biomaterials Developers: Distribution by Year of Establishment
Figure 5.9 Smart Biomaterials Developers: Distribution by Organization Size
Figure 5.10 Smart Biomaterials Developers: Distribution by Location of Headquarters (Region-wise)
Figure 5.11 Smart Biomaterials Developers: Distribution by Organization Size and Location of Headquarters (Region-wise)
Figure 5.12 Smart Biomaterials Developers: Distribution by Location of Headquarters (Country-wise)
Figure 6.1 Benchmarking Analysis (4D Bioprinter Developers): Distribution by Location of Headquarters and Organization Size
Figure 6.2 Competitive Benchmarking: Distribution of Very Small and Small Players based in North America (Peer Group I)
Figure 6.3 Competitive Benchmarking: Distribution of Mid-Sized, Large and Very Large Players based in North America (Peer Group II)
Figure 6.4 Competitive Benchmarking: Distribution of Very Small and Small Players based in Europe, Asia-Pacific and Rest of the World (Peer Group III)
Figure 6.5 Competitive Benchmarking: Distribution of Mid-sized Players based in Europe, Asia-Pacific and Rest of the World (Peer Group IV)
Figure 6.6 Competitive Benchmarking: Distribution of Large and Very Large Players based in Europe, Asia-Pacific and Rest of the World (Peer Group V)
Figure 6.7 Benchmarking Analysis (Smart Biomaterial Developers): Distribution by Location of Headquarters and Organization Size
Figure 6.8 Competitive Benchmarking: Distribution of Very Small and Small Players based in North America (Peer Group I)
Figure 6.9 Competitive Benchmarking: Distribution of Large and Very Large Players based in North America (Peer Group II)
Figure 6.10 Competitive Benchmarking: Distribution of Very Small and Small Players based in Europe, Asia-Pacific and Rest of the World (Peer Group III)
Figure 6.11 Competitive Benchmarking: Distribution of Mid-sized Players based in Europe, Asia-Pacific and Rest of the World (Peer Group IV)
Figure 6.12 Competitive Benchmarking: Distribution of Large and Very Large Players based in Europe, Asia-Pacific and Rest of the World (Peer Group V)
Figure 7.1 Product Competitiveness Analysis: Distribution of 4D Bioprinters Developed by North America based Players
Figure 7.2 Product Competitiveness Analysis: Distribution of 4D Bioprinters Developed by Europe based Players
Figure 7.3 Product Competitiveness Analysis: Distribution of 4D Bioprinters Developed by Asia-Pacific and Rest of the World based Players
Figure 8.1 Stratasys: Annual Revenues, 2017-H1 2022 (USD Million)
Figure 8.2 Enovis: Annual Revenues, 2017-H1 2022 (USD Billion)
Figure 9.1 Publication Benchmarking Analysis: Cumulative Year-wise Trend, 2016-2022
Figure 9.2 Publication Benchmarking Analysis: Distribution by Type of Article
Figure 9.3 Word Cloud Analysis: Emerging Focus Areas
Figure 9.4 Popular Publishers: Distribution by Number of Publications
Figure 9.5 Popular Journals: Distribution by Number of Publications
Figure 9.6 Publications Benchmarking Analysis: Distribution by Journal Impact Factor
Figure 9.7 Popular Journals: Distribution by Journal Impact Factor
Figure 9.8 Popular Funding Bodies: Distribution by Number of Publications
Figure 9.9 Publication Benchmarking
Figure 10.1 Porter’s Five Forces: Key Parameters
Figure 10.2 Porter’s Five Forces: Harvey Ball Analysis
Figure 11.1 Global 4D Bioprinting Market, 2023-2035 (USD Million)
Figure 11.2 4D Bioprinting Market: Distribution by Type of Technology, 2028 and 2035 (USD Million)
Figure 11.3 4D Bioprinting Market for Extrusion-based Technology, 2023-2035 (USD Million)
Figure 11.4 4D Bioprinting Market for Laser-based Technology, 2023-2035 (USD Million)
Figure 11.5 4D Bioprinting Market for Inkjet-based Technology, 2023-2035 (USD Million)
Figure 11.6 4D Bioprinting Market for Other Technologies, 2023-2035 (USD Million)
Figure 11.7 4D Bioprinting Market: Distribution by Application Area, 2028 and 2035 (USD Million)
Figure 11.8 4D Bioprinting Market for Biomedical Applications, 2023-2035 (USD Million)
Figure 11.9 4D Bioprinting Market for Other Applications, 2023-2035 (USD Million)
Figure 11.10 4D Bioprinting Market: Distribution by End-user, 2028 and 2035 (USD Million)
Figure 11.11 4D Bioprinting Market for Pharmaceutical and Biotechnology Companies, 2023-2035 (USD Million)
Figure 11.12 4D Bioprinting Market for Academic Research and Development, 2023-2035 (USD Million)
Figure 11.13 4D Bioprinting Market for Other End-users, 2023-2035 (USD Million)
Figure 11.14 4D Bioprinting Market: Distribution by Key Geographical Regions, 2028 and 2035 (USD Million)
Figure 11.15 4D Bioprinting Market in North America, 2023-2035 (USD Million)
Figure 11.16 4D Bioprinting Market in Europe, 2023-2035 (USD Million)
Figure 11.17 4D Bioprinting Market in Asia-Pacific, 2023-2035 (USD Million)
Figure 11.18 4D Bioprinting Market in Latin America, 2023-2035 (USD Million)
Figure 11.19 4D Bioprinting Market in Middle East and North Africa, 2023-2035 (USD Million)
Figure 12.1 Concluding Remarks: Current Market Landscape of 4D Bioprinters
Figure 12.2 Concluding Remarks: Current Market Landscape of Smart Biomaterials
Figure 12.3 Concluding Remarks: Publication Benchmarking Analysis
Figure 12.4 Concluding Remarks: Market Forecast and Opportunity Analysis

List Of Tables

Table 4.1 4D Bioprinters: Information on Status of Development and Type of Biomaterial,
Table 4.2 4D Bioprinters: Information on Type of Technology and Type of Stimulus Used,
Table 4.3 4D Bioprinters: Information on Product Specifications, Application Area(s) and End-user(s)
Table 4.4 4D Bioprinters Developers: Information on Year of Establishment, Number of Employees, Company Size, Location of Headquarters
Table 5.1 Smart Biomaterials: Information on Status of Development, Type of Biomaterial and Form of Biomaterial,
Table 5.2 Smart Biomaterials: Information on Type of Stimulus Used and Application Area(s),
Table 5.3 Smart Biomaterial Developers: Information on Year of Establishment, Number of Employees, Company Size, and Location of Headquarters
Table 6.1 Benchmarking Analysis (4D Bioprinter Developers): Information on Peer Groups
Table 6.2 Benchmarking Analysis (Smart Biomaterial Developers): Information on Peer Groups
Table 8.1 4D Bioprinter Developers: List of Companies Profiled
Table 8.2 Poietis: Company Overview
Table 8.3 Poietis: Product Portfolio
Table 8.4 Poietis: Recent Developments and Future Outlook
Table 8.5 REGENHU: Company Overview
Table 8.6 REGENHU: Product Portfolio
Table 8.7 REGENHU: Recent Developments and Future Outlook
Table 8.8 ROKIT Healthcare: Company Overview
Table 8.9 ROKIT Healthcare: Product Portfolio
Table 8.10 ROKIT Healthcare: Recent Developments and Future Outlook
Table 8.11 SMART3D: Company Overview
Table 8.12 SMART3D: Product Portfolio
Table 8.13 SMART3D: Recent Developments and Future Outlook
Table 8.14 Stratasys: Company Overview
Table 8.15 Stratasys: Product Portfolio
Table 8.16 Stratasys: Recent Developments and Future Outlook
Table 8.17 VIVAX BIO: Company Overview
Table 8.18 VIVAX BIO: Product Portfolio
Table 8.19 VIVAX BIO: Recent Developments and Future Outlook
Table 8.20 Smart Biomaterial Developers: List of Companies Profiled
Table 8.21 DirectSync Surgical: Company Overview
Table 8.22 DirectSync Surgical: Product Portfolio
Table 8.23 DirectSync Surgical: Recent Developments and Future Outlook
Table 8.24 Enovis: Company Overview
Table 8.25 Enovis: Product Portfolio
Table 8.26 Enovis: Recent Developments and Future Outlook
Table 8.27 Ferentis: Company Overview
Table 8.28 Ferentis: Product Portfolio
Table 8.29 Ferentis: Recent Developments and Future Outlook
Table 8.30 Sculpteo: Company Overview
Table 8.31 Sculpteo: Product Portfolio
Table 8.32 Sculpteo: Recent Developments and Future Outlook
Table 9.1 Timeline Analysis: Distribution by Type of Article and Average Time to Publish
Table 9.2 Timeline Analysis: Distribution by Type of Article and Maximum Time to Publish
Table 9.3 Timeline Analysis: Distribution by Type of Article and Minimum Time to Publish
Table 9.4 Timeline Analysis: Distribution by Journal Impact Factor and Average Time to Publish
Table 9.5 Timeline Analysis: Distribution by Journal Impact Factor and Maximum Time to Publish
Table 9.6 Timeline Analysis: Distribution by Journal Impact Factor and Minimum Time to Publish
Table 9.7 Publication Benchmarking: List of Top 35 Publications
Table 13.1 Avay Biosciences: Company Overview
Table 13.2 CURAM: Company Overview
Table 14.1 4D Bioprinters: Distribution by Status of Development
Table 14.2 4D Bioprinters: Distribution by Type of Biomaterial
Table 14.3 4D Bioprinters: Distribution by Status of Development and Type of Biomaterial
Table 14.4 4D Bioprinters: Distribution by Type of Technology
Table 14.5 4D Bioprinters: Distribution by Status of Development and Type of Technology
Table 14.6 4D Bioprinters: Distribution by Type of Stimulus Used
Table 14.7 4D Bioprinters: Distribution by Status of Development and Type of Stimulus Used
Table 14.8 4D Bioprinters: Distribution by Product Specifications
Table 14.9 4D Bioprinters: Distribution by Application Area(s)
Table 14.10 4D Bioprinters: Distribution by End-user(s)
Table 14.11 4D Bioprinter Developers: Distribution by Year of Establishment
Table 14.12 4D Bioprinter Developers: Distribution by Organization Size
Table 14.13 4D Bioprinter Developers: Distribution by Location of Headquarters (Region-wise)
Table 14.14 4D Bioprinter Developers: Distribution by Organization Size and Location of Headquarters (Region-wise)
Table 14.15 4D Bioprinter Developers: Distribution by Location of Headquarters (Country-wise)
Table 14.16 Smart Biomaterials: Distribution by Status of Development
Table 14.17 Smart Biomaterials: Distribution by Type of Biomaterial
Table 14.18 Smart Biomaterials: Distribution by Status of Development and Type of Biomaterial
Table 14.19 Smart Biomaterials: Distribution by Form of Biomaterial
Table 14.20 Smart Biomaterials: Distribution by Type of Stimulus Used
Table 14.21 Smart Biomaterials: Distribution by Status of development and Type of Stimulus Used
Table 14.22 Smart Biomaterials: Distribution by Application Area(s)
Table 14.23 Smart Biomaterials Developers: Distribution by Year of Establishment
Table 14.24 Smart Biomaterials Developers: Distribution by Organization Size
Table 14.25 Smart Biomaterials Developers: Distribution by Location of Headquarters (Region-wise)
Table 14.26 Smart Biomaterials Developers: Distribution by Organization Size and Location of Headquarters (Region-wise)
Table 14.27 Smart Biomaterials Developers: Distribution by Location of Headquarters (Country-wise)
Table 14.28 Benchmarking Analysis (4D Bioprinter Developers): Distribution by Location of Headquarters and Organization Size
Table 14.29 Benchmarking Analysis (Smart Biomaterial Developers): Distribution by Location of Headquarters and Organization Size
Table 14.30 Stratasys: Annual Revenues, 2017-H1 2022 (USD Million)
Table 14.31 Enovis: Annual Revenues, 2017-H1 2022 (USD Billion)
Table 14.32 Publication Benchmarking Analysis: Cumulative Year-wise Trend, 2016-2022
Table 14.33 Publication Benchmarking Analysis: Distribution by Type of Article
Table 14.34 Popular Publishers: Distribution by Number of Publications
Table 14.35 Popular Journals: Distribution by Number of Publications
Table 14.36 Publications Benchmarking Analysis: Distribution by Journal Impact Factor
Table 14.37 Popular Journals: Distribution by Journal Impact Factor
Table 14.38 Popular Funding Bodies: Distribution by Number of Publications
Table 14.39 Global 4D Bioprinting Market, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.40 4D Bioprinting Market: Distribution by Type of Technology, 2028 and 2035 (USD Million)
Table 14.41 4D Bioprinting Market for Extrusion-based Technology, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.42 4D Bioprinting Market for Laser-based Technology, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.43 4D Bioprinting Market for Inkjet-based Technology, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.44 4D Bioprinting Market for Other Technologies, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.45 4D Bioprinting Market: Distribution by Application Area, 2028 and 2035 (USD Million)
Table 14.46 4D Bioprinting Market for Biomedical Applications, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.47 4D Bioprinting Market for Other Applications, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.48 4D Bioprinting Market: Distribution by End-user, 2028 and 2035 (USD Million)
Table 14.49 4D Bioprinting Market for Pharmaceutical and Biotechnology Companies, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.50 4D Bioprinting Market for Academic Research and Development, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.51 4D Bioprinting Market for Other End-users, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.52 4D Bioprinting Market: Distribution by Key Geographical Regions, 2028 and 2035 (USD Million)
Table 14.53 4D Bioprinting Market in North America, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.54 4D Bioprinting Market in Europe, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.55 4D Bioprinting Market in Asia-Pacific, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.56 4D Bioprinting Market in Latin America, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)
Table 14.57 4D Bioprinting Market in Middle East and North Africa, Conservative, Base and Optimistic Scenario, 2023-2035 (USD Million)

List Of Companies

  1. 3D Systems
  2. 3d.FAB
  3. 3DBio Therapeutics
  4. 4D Biomaterials
  5. Avay Biosciences
  6. BIH Center for Regenerative Therapies (BCRT)
  7. BioG3D
  8. Brighter
  9. CELLINK
  10. CURAM
  11. Production and Validation Center for Advanced Therapies (Creatio)
  12. DJO® (now part of Envis)
  13. Duke University
  14. ETH Zurich
  15. Evoke Medical
  16. Ferentis
  17. First Graphene
  18. GKSS Research Center Geesthacht
  19. Grolltex
  20. Guangzhou Medical University
  21. Harvard Medical School
  22. Harvard University
  23. Institute of Polymer Research (Part of University of Waterloo)
  24. Instituto de Nanociencia y Materiales de Aragón
  25. Interdisciplinary Research Center of Autoimmune Diseases (Part of University of Eastern Piedmont)
  26. Leibniz Institute of Polymer Research Dresden
  27. Maastrich University
  28. Massachusetts Institute of Technology
  29. mimiX Biotherapeutics
  30. mNEMOSCIENCE
  31. Nano3D Biosciences
  32. NanoBio Lab
  33. National Interuniversity Consortium of Materials Science and Technology
  34. National Natural Science Foundation of China
  35. National Science Foundation
  36. Nuclera
  37. Ourobionics
  38. PhotoPolymer
  39. Poietis
  40. Politecbico di Milano
  41. Precise Bio
  42. Readily3D
  43. REGENHU
  44. Rheolution
  45. Ritsumeikan University
  46. ROKIT Healthcare
  47. Rutgers University
  48. RWTH Aachen University
  49. Sculpteo
  50. Smart3D
  51. Stratasys
  52. The George Washington University
  53. Tissue Regeneration Systems
  54. TissueLabs
  55. University of Bayreuth
  56. University of Birmingham
  57. University of California
  58. University of Chicago
  59. University of Eastern Piedmont
  60. University of Georgia
  61. University of Illinois
  62. University of Illinois Chicago
  63. University of Illinois Urbana-Champaign
  64. University of Maryland
  65. University of Tsukuba
  66. University of Twente
  67. University of Washington
  68. University of Wollongong
  69. Virginia Tech
  70. VIVAX BIO
  71. Wyss Institute for Biologically Inspired Engineering

Source 1: https://www.sciencedirect.com/science/article/pii/S1742706119307172#sec0015
Source 2: https://www.azom.com/article.aspx?ArticleID=19378

PRICING DETAILS

USD 4,799

This license grants the right of use of the purchased report to a single recipient only (normally the person who buys the report). You may access the material on your computer, as and when required, for your own personal use. You may also print Read more

This license grants the right of use of the purchased report by the employees of a business unit at a particular site/office location. The report may be accessed on the computer of any employee within the business unit. You may also print multiple Read more

This license grants the right of use of the purchased report by a department / team of individuals (up to 12) in a particular organization. The license does not limit the use to a particular site / office location. The report may be accessed on the computer Read more

This license entitles the buyer of the report to share, distribute the report (either full or in part) with other employees of the same firm/enterprise. The report may be accessed by any employee of the enterprise and there is no limit on the Read more

Discounts available for multiple report purchases
Click here to send an email to Roots Analysis team. sales@rootsanalysis.com